Vigil Neuroscience

Vigil Neuroscience

  • Founded: 2020
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: ALSP
  • Drug types: NEU, RAR, GEN
  • Lead product: VGL101
  • Product link: https://www.vigilneuro.com/pipeline
  • Funding: $98M IPO Jan 2022; $90M B Aug 2021; $50M A Dec 2020


vigilneuro.com

linkedin.com

job board


Short description:

Microglia-based Therapeutics for Neurodegenerative Diseases

Drug notes:

Also Clin0 other leukodystrophies; undisclosed Clin0 Alzheimer's

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Vigil Neuroscience
VP, Regulatory Affairs & Quality
Watertown, MA|51 days ago
Apply


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com